LDL-Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) Risk

Richard Ofori-Asenso
, Sophia Zoungas
, Andrew Tonkin
, Danny Liew

Research output: Contribution to journal › Comment / Debate › Other › peer-review

15 Citations (Scopus)

Original language	English
Pages (from-to)	235-238
Number of pages	4
Journal	Clinical Pharmacology and Therapeutics
Volume	104
Issue number	2
DOIs	https://doi.org/10.1002/cpt.1125
Publication status	Published - 1 Aug 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1002/cpt.1125

Other files and links

Link to publication in Scopus

Cite this

@article{0ff8b395e5524853b4dd4e04eb77b959,

title = "LDL-Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) Risk",

author = "Richard Ofori-Asenso and Sophia Zoungas and Andrew Tonkin and Danny Liew",

year = "2018",

month = aug,

day = "1",

doi = "10.1002/cpt.1125",

language = "English",

volume = "104",

pages = "235--238",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "John Wiley \& Sons",

number = "2",

}

TY - JOUR

T1 - LDL-Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) Risk

AU - Ofori-Asenso, Richard

AU - Zoungas, Sophia

AU - Tonkin, Andrew

AU - Liew, Danny

PY - 2018/8/1

Y1 - 2018/8/1

UR - https://www.scopus.com/pages/publications/85050691024

U2 - 10.1002/cpt.1125

DO - 10.1002/cpt.1125

M3 - Comment / Debate

AN - SCOPUS:85050691024

SN - 0009-9236

VL - 104

SP - 235

EP - 238

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 2

ER -